Skip to content

Targetedlibrary

Targetedlibrary

  • Home
  • Sample Page
    • Home
    • 2025
    • December
    • 14
Uncategorized

G created for use for the treatment of T2DM as

Chemexpress December 14, 2025 0 Comments

G created for use for the therapy of T2DM as monotherapy, and in mixture with existing therapies which includes metformin. In this study, no effect of remogliflozin etabonate on metformin…

Recent Posts

  • 3-(4-Hydroxy-phenyl)-4,5-dihydro-isoxazole-5-carboxylic acid methylamide
  • 3-(4-ethyl-5-mercapto-4H-1,2,4-triazol-3-yl)propanamide
  • 3,4-Dimethoxycinnamic acid, predominantly trans (CAS 2316-26-9)
  • 3,4-Dihydro-7-hydroxyquinoline-2(1H)-one (CAS 22246-18-0)
  • (3,4-Dihydro-1-naphthyloxy)trimethylsilane (CAS 38858-72-9)

Recent Comments

  1. A WordPress Commenter on Hello world!

You Missed

Uncategorized

3-(4-Hydroxy-phenyl)-4,5-dihydro-isoxazole-5-carboxylic acid methylamide

Uncategorized

3-(4-ethyl-5-mercapto-4H-1,2,4-triazol-3-yl)propanamide

Uncategorized

3,4-Dimethoxycinnamic acid, predominantly trans (CAS 2316-26-9)

Uncategorized

3,4-Dihydro-7-hydroxyquinoline-2(1H)-one (CAS 22246-18-0)

Targetedlibrary

Copyright © All rights reserved | Blogus by Themeansar.